«

»

CMS allows Medicare Advantage plans to negotiate Part B drug prices, implement step therapy

In a significant move meant to foster competition, allowing Medicare Advantage plans to negotiate Part B drug prices will generate cost savings that they then can pass on to consumers, the agency says.

Read the full post at FierceHealthcare: Payer
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive